Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?

American Journal of Infection Control

Volumn 32, Issue 4, 2004, Pages 220-223

  Tamim, Hala ^a   Musharrafieh, Umayya ^a   Ramia, Sami ^a   Almawi, Wassim Y ^b   Al Jisr, Tamima ^c   Ayoub, Tanios ^d   Nabulsi Majzoub, Malak ^e   Kazma, Hassan ^f   Baz, Elizabeth Kfoury ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b ARABIAN GULF UNIVERSITY   (Bahrain)

^c MAKASSED GENERAL HOSPITAL   (Lebanon)

^d Amel Mountain Hospital   (Lebanon)

^e Islamic Hospital Tripoli   (Lebanon)

^f Hammoud Hospital   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; LEBANON; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SCREENING; SEROPREVALENCE; VIRUS TRANSMISSION; WESTERN BLOTTING;

EID: 3042759131     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2003.10.012     Document Type: Article

References (40)

1. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 77:1980;7415-7419
2. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K.I., et al. Adult-T-cell-leukemia antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 78:1981;6476-6480
3. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 2:1985;407-410
4. Soriano V., Gutierrez M., Vallejo A., Aguilera A., Pujol E., Calderon E., et al. Epidemiology of HTLV-I infection in Spain. HTLV Spanish Study Group. Int J Epidemiol. 25:1996;443-449
5. Blattner WA. Epidemiology of HTLV-I and associated diseases in human retrovirology. London: Raven Press; p. 251-66.
6. Wiley C.A., Nerenberg M., Cros D., Soto-Aguilar M.C. HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus. N Engl J Med. 320:1989;992-995
7. Rosenblatt J.D., Golde D.W., Wachsman W., Giorgi J.V., Jacobs A., Schmidt G.M., et al. A second isolate of HTLV-II assoicated with atypical hairy cell-cell leukemia. N Engl J Med. 315:1986;372-377
8. Kalyanaraman V.S., Sarngadharan M.G., Robert-Guroff M., Miyoshi I., Golde D., Gallo R.C. A new type of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 218:1982;571-573
9. Saxon A., Stevens R.H., Golde D.W. T-lymphocyte variant of T-cell leukemia. Ann Intern Med. 88:1978;323-326
10. Senyuta N., Syrtsev A., Yamashita M., Stepina V., Susova O., Scherbak L., et al. Sero-epidemiologic and phylogenetic studies of HTLV-I infection in 2 countries of the Caspian Sea region. Int J Cancer. 77:1998;488-493
11. Rasulee A., Le Riverend E., Shih J., Senjuta N., Pavlish O., Syrtsev A., et al. HTLV-I seroprevalence in blood donors in Cuba. Int J Cancer. 54:1993;885-886
12. Levine P.H., Blattner W.A., Clark J., Tarone R., Maloney E.M., Murphy E.M., et al. Geographic distribution of HTLV-I and identification of a new high-risk population. Int J Cancer. 42:1988;7-12
13. Williams C.K., Dada A., Blattner W.A. Some epidemiological features of the human T-cell lymphotropic virus type I (HTLV-I) and ATL in Nigerians. Leukemia. 8:(Suppl 1):1994;S77-S82
14. Blattner W.A., Nomura A., Clark J.W., Ho G.Y., Nakao Y., Gallo R., et al. Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. Proc Natl Acad Sci U.S.A. 83:1986;4895-4898
15. Murovska M., Taguchi H., Iwahara Y., Sawada T., Kukaine R., Miyoshi I. Antibodies to HTLV-I among blood donors in Latvia, USSR. Int J Cancer. 47:1991;158-159
16. Dalekos G.N., Zervou E., Karabini F., Elisaf M., Bourantas K., Siamopoulos K.C. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece. Transfusion. 35:1995;503-506
17. Gurtsevitch V., Senyuta N., Shih J., Stepina V., Pavlish O., Syrtsev A., et al. HTLV-I infection among Nivkhi people in Sakhalin. Int J Cancer. 60:1995;432-433
18. Arif M., Ramia S. Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia. Ann Trop Med Parasitol. 92:1998;305-309
19. Constantine N.T., Fathi Sheba M., Corwin A.L., Danahy R.S., Callahan J.D., Watts D.M. A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt. Epidemiol Infect. 107:1991;429-433
20. Al-Mufti S., Voevodin A., Ahmed S., Al-Hamdan S., Al-Bisher A.A. Prevalence of human T-cell lymphotropic virus type I infection among volunteer blood donors in Kuwait. J Acquir Immune Defic Syndr Hum Retrovirol. 15:1997;88-90
21. Knox-Macaulay H., McDonald R., al-Busaidy S., Ali N. HTLV-I seroprevalence in the Sultanate of Oman. Scand J Infect Dis. 29:1997;217-218
22. Meytes D., Schochat B., Lee H., Nadel G., Sidi Y., Cerney M., et al. Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group. Lancet. 336:1990;1533-1535
23. Monplaisir N., Neisson-Vernant C., Bouillot M., Duc-Dodon M., Ugarte E., Valette I., et al. HTLV-I maternal transmission in Martinique, using serology and polymerase chain reaction. AIDS Res Hum Retroviruses. 9:1993;869-874
24. Sullivan M.T., Williams A.E., Fang C.T., Notari E.P., Poiesz B.J., Ehrlich G.D. Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts and family members of blood donors who are seropositive for HTLV type I or II. American Red Cross HTLV-I/II Collaborative Study Group. Transfusion. 33:1993;585-590
25. Reeves W.C., Saxinger C., Brenes M.M., Quiroz E., Clark J.W., Hoh M.W., et al. Human T-cell lymhotropic virus type I (HTLV-I) seroepidemiology and risk factors in Metropolotan Panama. Am J Epid. 127:1988;532-539
26. Ando Y., Nakano S., Saito K., Shimamoto I., Ichijo M., Toyama T., et al. Prevention of HTLV-I transmission through the breast milk by a freeze thawimg process. Jpn J Cancer Res. 77:1986;974-977
27. Hino S., Yamaguchi K., Katamine S., Sugiyama H., Amagasaki T., Kinoshita K., et al. Mother to child transmission of human T-cell leukemia virus type-1. Jpn J Cancer Res. 76:1985;474-480
28. Blomberg J., Moestrup T., Frimand J., Hansson B.G., Krogsgaard K., Grillner L., et al. HTLV-I and -II in intravenous drug users from Sweden and Denmark. Scand J Infect Dis. 26:1994;23-26
29. Kajiyama W., Kashiwagi S., Ikematsu H., Hayashi J., Nomura H., Okochi K. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis. 154:1986;851-857
30. Kleinman S., Swanson P., Allain J.P., Lee H. Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion. 33:1993;14-18
31. Okochi K., Sato H., Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 46:1984;245-253
32. Proposed WHO criteria for interpreting results from Westernblot assays for HIV-I, HIV-II and HTLV-I/HTLV-II. Wkly Epidemiol Rec. 65:1990;281-283
33. Pagliuca A., Pawson R., Mufti G.J. HTLV-I screening in Britain. BMJ. 311:1995;1313-1314
34. Kamihira S., Nakasima S., Oyakawa Y., Moriuti Y., Ichimaru M., Okuda H., et al. Transmission of human T cell lymphotropic virus type I by blood transfusion before and after mass screening of sera from seropositive donors. Vox Sang. 52:1987;43-44
35. Naman R., Klayme S., Naboulsi M., Mokhbat J., Jradi O., Ramia S. HTLV-I and HTLV-II infections in volunteer blood donors and high risk groups in Lebanon. J Infect. 45:2002;29-31
36. Matar G., Traboulsi R., Abdelnour A., Oseiran M. Serosurvey of HTLV-I/II in a selected population in Lebanon. Revue Medicale Libanaise. 8:1996;23-24
37. International Agency for Research on Cancer. Human immunodeficiency and virus and human T-cell lymphotropic viruses. 1996;IARC, Lyons. IARC Monographs on evaluation of Carcinogenic Risk to Human, Vol. 67
38. Kaplan J.E., Osame M., Kubota H., Igata A., Nishitani H., Maeda Y., et al. The risk of development of HTLV-I associated myelopathy/tropical spastic paraparesis among persons among infected with HTLV-I. J Acquir Immun Defic Syndr. 3:1990;1096-1101
39. Brennan M., Runganga J., Barbara J.A., Contreras M., Tedder R.S., Garson J.A., et al. Prevalence of antibodies to human T cell leukemia/lymphoma virus in blood donors in north London. BMJ. 307:1993;1235-1239
40. Weber J. HTLV-I infection in Britain. BMJ. 301:1990;71-72